GHK-Cu: Copper Peptide Research Across Skin, Wound Healing, and Cognition

What is GHK-Cu?

GHK is a tripeptide of glycine, histidine and lysine. GHK-Cu is that sequence bound to a copper ion, and the distinction matters: the coordination complex, rather than the bare peptide, is what the research literature is generally describing.

The scope of this article is worth stating plainly. It sets out what has been reported in the published literature about a compound supplied strictly as a reagent for in vitro laboratory research. It does not describe human use, offers no guidance of any kind, and makes no claim about outcomes in people. What follows is scientific context and nothing more.

Origin and complex chemistry

GHK occurs naturally in human plasma, and its concentration has been reported to decline with age, which is part of why it became a subject of study in the first place. The peptide has been described in reviews as a copper-binding sequence with a role in tissue remodelling^[2].

The binding itself has been examined computationally. The histidine imidazole nitrogen and the terminal amine give the sequence a high affinity for copper, and theoretical work has modelled the geometry and energetics of copper coordination to the GHK sequence^[5]. In practice this makes the complex more sensitive to pH and buffer composition than the uncomplexed peptides elsewhere in a catalogue, and it is the reason a colour change accompanies complex formation.

Mechanisms in skin research

The dermal literature is where GHK-Cu appears most often. Reviews have associated the complex with broad changes in gene expression relevant to matrix remodelling^[1], which is a different kind of claim from a direct structural one: the reported activity is transcriptional rather than a matter of the peptide acting as a building block.

Related review work has framed the sequence in the context of tissue remodelling and extracellular matrix turnover^[2]. Laboratory work in this area is typically fibroblast culture, matrix biology assays and analytical characterisation of the complex by spectroscopy.

Mechanisms in wound healing research

A second body of work concerns models of skin wound repair. Synthetic analogues of the GHK sequence have been examined for wound healing properties in animal models^[3], with the comparison across analogues used to probe which structural features carry the observed activity.

As with the dermal work, these are preclinical models. Findings in animal wound models do not establish anything about people, and the analogue comparisons are best read as structure-activity investigations rather than as conclusions about the parent complex.

The cognitive research direction

A third and more recent direction concerns the nervous system. Gene expression analysis has examined the effect of GHK on transcripts relevant to nervous system function and cognitive decline^[4], an approach that identifies candidate pathways rather than demonstrating an effect on cognition itself.

This is the least developed of the three directions and should be read accordingly. Transcriptional signals are a starting point for investigation, not an outcome.

Regulatory Status

GHK-Cu is not an approved medicine. It has not been authorised by the MHRA, the EMA, the FDA or any other regulator for human or veterinary use, and it holds no marketing authorisation of any kind.

That is why it is handled as a research compound. Axiom supplies it for laboratory research use only. It is not a licensed product and not a supplement, and the account above is offered as scientific context, not as guidance of any other kind.

Handling in the research setting

Handling matters more here than for most sequences, because the active species is a coordination complex. The complex is light-sensitive and pH-sensitive, and reconstitution conditions affect its stability. Recording the diluent alongside the batch number, keeping lyophilised material at low temperature and limiting how often a vial is accessed are all standard practice.

Summary

GHK-Cu is a naturally occurring tripeptide bound to copper, and it is the coordination complex rather than the bare sequence that the literature generally describes. Three research directions dominate: matrix and gene expression work in dermal models, wound repair models using synthetic analogues, and more recent transcriptional work relevant to nervous system function. All of it is preclinical, and none of it establishes an effect in people. The complex is unapproved by any regulator and is supplied strictly for in vitro laboratory research. For working out concentrations from vial mass and solvent volume, see our reconstitution calculator.